Is it Time to Start Screening for Herpes?

Should herpes be part of a routine STI checkup? For years the answer has been no—the old antibody tests gave too many false positives, and many doctors weren’t convinced that knowing your status actually helped. In this talk, leading researcher at UCLA and HCA Board Member Dr. Lao-Tzu Allan-Blitz takes a fresh look at that question, exploring why better tests, stronger evidence that treatment can reduce transmission, and promising new medications may finally be tipping the balance toward screening people who want to know their herpes status.

About Dr. Lao-Tzu Allan-Blitz:
Dr. Lao-Tzu Allan-Blitz is an Assistant Professor of medicine at the University of California, Los Angeles and the David Geffen School of Medicine. As a physician, he cares for both adults and children. Dr. Allan-Blitz’s research focuses on addressing disparities in sexual health equity, combining laboratory-based diagnostic development with public health field implementation programs. He has specific expertise in developing low-cost, CRISPR-based tests for detecting sexually transmitted pathogens. Dr. Allan-Blitz has worked in numerous global settings. He believes that access to high-quality healthcare is a human right and views diagnostic tests as a fundamental component of high-quality healthcare.

Register on Zoom here: https://us06web.zoom.us/meeting/register/bOS8lNmxSR2zoJulSQVSlw